Fig. 5From: Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptomsCorrelations between acute genitourinary (GU) toxicity grade (A, B), acute gastrointestinal (GI) toxicity grade (C, D), and serum concentrations of IL-6 and TGF-β1 after the 25th fraction in patients with prostate cancer treated with radiotherapyBack to article page